Suven Life Sciences Limited (SUVEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.368x

Based on the latest financial reports, Suven Life Sciences Limited (SUVEN) has a cash flow conversion efficiency ratio of -0.368x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.03 Billion ≈ $-11.18 Million USD) by net assets (Rs2.81 Billion ≈ $30.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SUVEN company net worth for the company's overall valuation and market capitalisation.

Suven Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Suven Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Suven Life Sciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suven Life Sciences Limited ranked by their cash flow conversion efficiency. Explore SUVEN cash flow quality score to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Under Armour Inc C
NYSE:UA
0.076x
Tianjin Tianyao Pharmaceuticals Co Ltd
SHG:600488
0.003x
SANDUR MANGANESE AND IRON ORES LTD
NSE:SANDUMA
0.104x
Anhui Xinlong Electrical Co Ltd
SHE:002298
0.036x
Crystal Growth & Energy Equipment Co. Ltd. A
SHG:688478
N/A
Shenyang Toly Bread Co Ltd
SHG:603866
0.043x
Primax Electronics Ltd
TW:4915
0.053x
Redcare Pharmacy NV
F:RDC
-0.039x

Annual Cash Flow Conversion Efficiency for Suven Life Sciences Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Suven Life Sciences Limited from 2005 to 2025. View current stock price of Suven Life Sciences Limited for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs1.10 Billion
≈ $11.89 Million
Rs-1.48 Billion
≈ $-16.06 Million
-1.350x -215.69%
2024-03-31 Rs2.70 Billion
≈ $29.20 Million
Rs-1.15 Billion
≈ $-12.49 Million
-0.428x -55.59%
2023-03-31 Rs3.75 Billion
≈ $40.59 Million
Rs-1.03 Billion
≈ $-11.16 Million
-0.275x +79.28%
2022-03-31 Rs961.45 Million
≈ $10.40 Million
Rs-1.28 Billion
≈ $-13.79 Million
-1.327x -49.20%
2021-03-31 Rs1.08 Billion
≈ $11.68 Million
Rs-960.24 Million
≈ $-10.38 Million
-0.889x +34.25%
2020-03-31 Rs1.43 Billion
≈ $15.50 Million
Rs-1.94 Billion
≈ $-20.96 Million
-1.352x -3261.03%
2019-03-31 Rs8.31 Billion
≈ $89.87 Million
Rs355.49 Million
≈ $3.84 Million
0.043x -53.06%
2018-03-31 Rs7.67 Billion
≈ $82.99 Million
Rs699.36 Million
≈ $7.56 Million
0.091x -44.15%
2017-03-31 Rs6.67 Billion
≈ $72.13 Million
Rs1.09 Billion
≈ $11.77 Million
0.163x +39.04%
2016-03-31 Rs5.95 Billion
≈ $64.40 Million
Rs698.78 Million
≈ $7.56 Million
0.117x -54.10%
2015-03-31 Rs5.59 Billion
≈ $60.49 Million
Rs1.43 Billion
≈ $15.46 Million
0.256x -44.27%
2014-03-31 Rs2.64 Billion
≈ $28.60 Million
Rs1.21 Billion
≈ $13.12 Million
0.459x +130.90%
2013-03-31 Rs1.54 Billion
≈ $16.70 Million
Rs306.86 Million
≈ $3.32 Million
0.199x -24.39%
2012-03-31 Rs1.28 Billion
≈ $13.79 Million
Rs335.07 Million
≈ $3.62 Million
0.263x +503.70%
2011-03-31 Rs1.27 Billion
≈ $13.71 Million
Rs55.16 Million
≈ $596.55K
0.044x -60.24%
2010-03-31 Rs1.18 Billion
≈ $12.77 Million
Rs129.25 Million
≈ $1.40 Million
0.109x -63.45%
2009-03-31 Rs1.14 Billion
≈ $12.38 Million
Rs342.73 Million
≈ $3.71 Million
0.299x +709.03%
2008-03-31 Rs1.06 Billion
≈ $11.51 Million
Rs39.38 Million
≈ $425.92K
0.037x -76.86%
2007-03-31 Rs1.02 Billion
≈ $10.98 Million
Rs162.41 Million
≈ $1.76 Million
0.160x +161.76%
2006-03-31 Rs902.12 Million
≈ $9.76 Million
Rs55.13 Million
≈ $596.25K
0.061x +135.07%
2005-03-31 Rs811.85 Million
≈ $8.78 Million
Rs21.11 Million
≈ $228.26K
0.026x --

About Suven Life Sciences Limited

NSE:SUVEN India Drug Manufacturers - Specialty & Generic
Market Cap
$974.11 Million
Rs90.07 Billion INR
Market Cap Rank
#9082 Global
#445 in India
Share Price
Rs341.55
Change (1 day)
-2.37%
52-Week Range
Rs126.65 - Rs392.05
All Time High
Rs392.05
About

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candida… Read more